Search


  


In the International Release, the  | Has active ingredient (attribute)| value should represent the base ingredient, not a modification, unless explicitly identified as an exception below.

Exceptions

Examples

Benzylpenicillin

1234765004 |Product containing only benzathine benzylpenicillin in parenteral dose form (medicinal product form)|

323404007 |Product containing benzathine benzylpenicillin (medicinal product)|

Chemical element with multiple modification

422232005 |Calcium lactate gluconate (substance)|

715220007 |Tenofovir alafenamide (substance)|

Chloral hydrate

778711000 |Product containing only chloral hydrate in oral dose form (medicinal product form)|

386735001 |Product containing chloral hydrate in oral dose form (medicinal product form)|

775158004 |Product containing only chloral hydrate (medicinal product)|

Liposome or lipid complex substances

426490000 |Vincristine liposome (substance)|

425953004 |Amphotericin B lipid complex (substance)|

768664009 |Amphotericin B phospholipid complex (substance)|

427544000 |Amphotericin B cholesteryl sulfate complex (substance)|

Pegylated substance

385544005 |Pegfilgrastim (substance)|

770965008 |Pegvaliase (substance)|

Radiopharmaceutical

783865003 |Product containing only cyanocobalamin (58-Co) (medicinal product)|

783867006 |Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form)|

783856005 |Product containing sodium iodide (131-I) in parenteral dose form (medicinal product form)|

783854008 |Product containing sodium iodide (131-I) (medicinal product)|

Silver sulfadiazine

864009007 |Product containing only silver sulfadiazine in cutaneous dose form (medicinal product form)|

771756000 |Product containing silver sulfadiazine in cutaneous dose form (medicinal product form)|


Feedback
  • No labels